October 28, 2014
Chiba University has issued an official warning to a professor involved in the university’s clinical study on Novartis Pharma’s hypertension drug Diovan (valsartan). According to the university, the 54-year-old professor at the Graduate School of Pharmaceutical Sciences instructed a graduate...read more